WW
Highly rated in
1
conditions
Highly rated in
1
conditions
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Wolfgang A. Weber's experience treating your condition:
About Dr. Wolfgang A. Weber

Wolfgang Weber is a Nuclear Medicine expert in New York, New York. Weber has been practicing medicine for over 30 years and is highly rated in 1 condition, according to our data. His top areas of expertise are Gastroesophageal Junction Cancer, Ptosis, Neurofibromatosis, Prostatectomy, and Gamma Knife Radiosurgery. He is licensed to treat patients in New York. Weber is currently accepting new patients.

His clinical research consists of co-authoring 325 peer reviewed articles and participating in 10 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Wolfgang A. Weber it is best to call his office and ask if your insurance is accepted.


Dr. Wolfgang A. Weber accepts the following insurance:

  •  Ambetter

Call to see if your plan is accepted.
Locations
1275 York Ave, New York, NY 10065
Background & Education
Graduate Institution
Other, 1993
Specialties
Nuclear Medicine
Licenses
Nuclear Imaging & Therapy in NY
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


10 Clinical Trials

Targeted Silica Nanoparticles for Real-Time Image-Guided Intraoperative Mapping of Nodal Metastases
A Phase I/II Study of the Fluorescent PARP1 Binding Imaging Agent PARPi-FL in Patients With Oral Squamous Cell Carcinomas
Therapy Optimisation for the Treatment of Hairy Cell Leukemia
Pilot Trial of PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer
PET Imaging of Thyroid Tissue Expressing Sodium-iodine Symporter Using the New Tracer 18F-tetrafluoroborate (18F-TFB)
Theranostics of Radiolabeled Somatostatin Antagonists 68Ga-DOTA-JR11 and 177Lu-DOTA-JR11 in Patients With Neuroendocrine Tumors
A Phase II Study of 68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer
Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme - a Randomised Phase II Trial
View 7 Less Clinical Trials -

325 Total Publications

A theranostic approach for CAR-T cell therapy.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors